Empyrean Therapeutics, Inc. | WebDisclosure

Basculer en Français

10161	Companies
208736	Keywords
138859	Articles
110648	Press releases

Headlines Articles Press releases Empyrean Therapeutics, Inc.

Home
Companies
Empyrean Therapeutics, Inc.

BRIEF

published on 11/25/2024 at 23:25, 1 year 4 months ago

Empyrean Therapeutics Acquires Novel Cancer Treatment Molecule

Cancer Treatment Pharmaceutical Acquisition Empyrean Therapeutics TLR-2 Antagonist R&D Innovation
BRIEF

published on 11/25/2024 at 23:25, 1 year 4 months ago

Empyrean Therapeutics acquiert une nouvelle molécule pour le traitement du cancer

Traitement Du Cancer Acquisition Pharmaceutique Thérapeutique Empyrean Antagoniste Du TLR-2 Innovation En R&D
PRESS RELEASE

published on 11/25/2024 at 23:20, 1 year 4 months ago

Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment
Empyrean Therapeutics, Inc. acquires novel cancer drug molecule EMS-312 from Eos Therapies, aiming to expedite development for brain, pancreatic, breast, and hard-to-treat cancers. Strategic move marks milestone. CEOs Kal Fishman and Doug Bonhaus express optimism

Empyrean Therapeutics Novel Cancer Drug EMS-312 Eos Therapies CEO Kal Fishman

Accesswire

Published on 04/02/2026 at 22:00, 2 days 1 hour ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 2 days 5 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 2 days 8 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 days 9 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 days 9 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/04/2026 at 10:07, 13 hours 35 minutes ago

Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 21 hours 37 minutes ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 1 day 5 hours ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago

IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 1 day 5 hours ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems

Les Echos

Published on 04/03/2026 at 18:46, 1 day 4 hours ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 1 day 4 hours ago

Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 1 day 5 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026

View all LES ECHOS COMFI WIRE